- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Public Companies
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Insights 413 results
Client Alert
January 26, 2022
Spotlight on PFAS and Other Substances in Cosmetics Likely to Grow in 2022
Client Alert
January 20, 2022
Supreme Court Stays OSHA Vaccine-or-Test Mandate for Large Businesses
Client Alert
January 14, 2022
Delaware Chancery Court Issues Highly-Anticipated SPAC-Related Decision
Client Alert
Client Alert
January 4, 2022
FDA Alerts Pharmaceutical Manufacturers to Risk of Benzene in Certain Drugs
Client Alert
December 10, 2021
OSHA Pushes Ahead With Final Vax Or Test Rule Despite Court Challenges
Article · Source: Texas Lawyers
December 3, 2021
Bipartisan Senate Infrastructure Bill Promotes Carbon Capture, Utilization and Sequestration
Client Alert
December 2, 2021
Major TCEQ Rulemaking Impacts Industrial Companies in Texas
Article · Source: Pratt’s Journal of Bankruptcy Law
December 1, 2021
"Take This Pill, It’s Good for You”: Fifth Circuit Concludes That Forced Change of Control Was Not the Product of Duress
Client Alert
December 1, 2021
Natural Gas Processing (NGP) Facilities Now Required to Report to EPA for the Toxics Release Inventory
Article · Source: Chamber Litigation Blog
November 11, 2021
Top False Claims Act Developments
Client Alert
November 10, 2021
Biden Administration Unveils New COVID-19 Vaccination and Testing Requirements for Large Businesses and Healthcare Workers